CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale Chief Financial Officer sold 24,002 shares at $1.28 ($30,723)
- 4 Planned sale Chief Human Resource Officer sold 7,534 shares at $1.28 ($9,644)
- 4 Planned sale President and CEO sold 89,375 shares at $1.28 ($114,400)
- 4 Planned sale Chief Operating Officer sold 6,917 shares at $1.28 ($8,854)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Human Resource Officer acquired 25,875 shares (grant or award)
- 4 Grant or award General Counsel & Corp. Sec'y acquired 35,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 40,150 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 45,650 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 56,650 shares (grant or award)
- 4 Grant or award President and CEO acquired 162,500 shares (grant or award)
Page 2 of 11 · 215 filings